EVOKE PHARMA INC - COM (EVOK)

CUSIP: 30049G104

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
2,287,040
Share change
-565,682
Total reported value
$4,756,000
Price per share
$2.08
Number of holders
20
Value change
-$1,210,619
Number of buys
3
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 30049G104?
CUSIP 30049G104 identifies EVOK - EVOKE PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVOKE PHARMA INC - COM (EVOK) as of Q1 2018

As of 31 Mar 2018, EVOKE PHARMA INC - COM (EVOK) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,287,040 shares. The largest 10 holders included VANGUARD GROUP INC, STATE TREASURER STATE OF MICHIGAN, SPHERA FUNDS MANAGEMENT LTD., Knoll Capital Management, LP, DEUTSCHE BANK AG\, 683 Capital Management, LLC, Creative Planning, BlackRock Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and NORTHERN TRUST CORP. This page lists 20 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.